BUY Gland Pharma Limited — Ashish Kyal, Waves Strategy Advisors
byAshish Kyal, Waves Strategy AdvisorsHorizon: NA (inferred Swing (≤2wk))16 Jul 2026via ET Now (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 advisors have active short-term BUY calls on this stock
Advisor consensus · adjacent horizon·7 Jul · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Gland Pharma
- BUY — Vishnu Kant Upadhyay, Master Capital Services13 Oct 2026 · ~3 months · target ₹3,400 · Active
- BUY — Kunal Parar, Choice Broking8 Oct 2026 · Same day · target ₹3,235 · Expired
- BUY — Prakash Gaba7 Oct 2026 · ~2 weeks · target ₹3,200 · SL hit
- BUY — Nomura India Research7 Oct 2026 · ~1 year · target ₹3,750 · Active
- BUY — Raja Venkatraman7 Oct 2026 · ~3 months · target ₹3,325 · SL hit
More from Ashish Kyal, Waves Strategy Advisors
- BUY Punjab National Bank14 Oct 2026 · Next day · target ₹125 · SL hit
- BUY L&T Technology Services14 Oct 2026 · ~1 year · target ₹3,800 · Target hit
- BUY Redington14 Oct 2026 · ~2 weeks · target ₹426 · SL hit
- BUY Info Edge (India)9 Oct 2026 · ~2 weeks · target ₹1,280 · Active
- BUY Colgate Palmolive (India)9 Oct 2026 · ~2 weeks · target ₹1,950 · SL hit

